Voyager Therapeutics Inc (VYGR) Insider Trading
- $92,031,920.32
- $16,235,902.68
- April 2, 2025
- Bernard Ravina
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 21, 2020 | COO | 3,724 | $13.36 | Sell | $49,752.64 | |
| Jan. 21, 2020 | CEO | 10,705 | $13.36 | Sell | $143,018.80 | |
| March 12, 2019 | Major Shareholder | 4,179,728 | $11.96 | Buy | $49,989,546.88 | |
| Sept. 12, 2018 | Director | 5,000 | $18.44 | Buy | $92,200.00 | |
| Sept. 10, 2018 | Director | 3,000 | $19.39 | Buy | $58,170.00 | |
| Aug. 17, 2018 | Director | 3,000 | $18.31 | Buy | $54,930.00 | |
| April 10, 2018 | Insider | 2,451 | $18.38 | Sell | $45,049.38 | |
| March 23, 2018 | CFO | 11,200 | $20.52 | Sell | $229,824.00 | |
| March 19, 2018 | CFO | 17,316 | $22.11 | Sell | $382,856.76 | |
| March 16, 2018 | CFO | 15,416 | $22.15 | Sell | $341,464.40 | |
| March 12, 2018 | Insider | 2,451 | $25.16 | Sell | $61,667.16 | |
| Feb. 27, 2018 | Insider | 15,623 | $30.00 | Sell | $468,690.00 | |
| Feb. 12, 2018 | Insider | 2,451 | $18.24 | Sell | $44,706.24 | |
| Jan. 10, 2018 | Insider | 3,630 | $16.40 | Sell | $59,532.00 | |
| Dec. 11, 2017 | Insider | 5,490 | $13.63 | Sell | $74,828.70 | |
| Nov. 10, 2017 | Insider | 5,490 | $13.26 | Sell | $72,797.40 | |
| Oct. 10, 2017 | Insider | 10,980 | $20.33 | Sell | $223,223.40 | |
| Sept. 11, 2017 | Insider | 16,470 | $12.87 | Sell | $211,968.90 | |
| Sept. 5, 2017 | Insider | 5,490 | $10.00 | Sell | $54,900.00 | |
| July 20, 2017 | Insider | 5,490 | $10.00 | Sell | $54,900.00 | |
| Jan. 14, 2016 | CEO | 10,000 | $14.07 | Buy | $140,700.00 |
Insiders are both buying and selling Voyager Therapeutics Inc stock.
The insider traders at Voyager Therapeutics Inc are: Bernard Ravina, Rock Ventures Iii L.P. Third, Todd Alfred Carter, Robert W Hesslein, Robin Swartz, Ecor1 Capital, Llc, Jane Henderson, Alfred Sandrock, Allison Dorval, Andre Turenne, Glenn Pierce, James A Geraghty, Julie Burek, Neurocrine Biosciences Inc, Peter P Pfreundschuh, PIERCE GLENN, Omar Khwaja, Matthew P Ottmer, Higgins Michael J, Sandell Jacquelyn Fahey, Steven M Paul, and Dinah Ph.D. Sah
The most active insider trader at Voyager Therapeutics Inc is Bernard Ravina with 10 trades.
Rock Ventures Iii L.P. Third has sold the most Voyager Therapeutics Inc stock with a total value of $9,263,849.52.
Neurocrine Biosciences Inc has bought the most Voyager Therapeutics Inc stock with a total value of $128,055,189.76.
The most recent insider trade for Voyager Therapeutics Inc was on April 2, 2025.
The single biggest insider buy for Voyager Therapeutics Inc was from Neurocrine Biosciences Inc with a total value of $49,989,546.88 on March 12, 2019.
The single biggest insider sell for Voyager Therapeutics Inc was from Ecor1 Capital, Llc with a total value of $3,497,520.00 on Jan. 9, 2023.